Martin J. van Den Bent, MD
Daniel Den Hoed Cancer Center at Erasmus Medical Center
7
0
7
N/A
0
0
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
+2 more interventions
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (7)
Research Network
Collaboration Network
Research Areas & Affiliations
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Amar Gajjar, MD
St. Jude Children's Research Hospital
Shared therapeutic areas:
Edward G. Shaw, MD
Wake Forest University Health Sciences
Shared therapeutic areas:
Jeffrey J. Raizer, MD
Robert H. Lurie Cancer Center
Shared therapeutic areas:
Jeffrey Raizer, MD
Northwestern University
Shared therapeutic areas:
Jeffrey A. Sosman, MD
Vanderbilt-Ingram Cancer Center
Shared therapeutic areas:
Thomas Kaley, MD
Memorial Sloan Kettering Cancer Center
Shared therapeutic areas:
Robert L. DeJager, MD, FACP
Daiichi Sankyo
Shared therapeutic areas:
Glenn J. Lesser, MD
Wake Forest University Health Sciences
Shared therapeutic areas:
Gianpaolo Pirovano, MD
Bracco Diagnostics, Inc
Shared therapeutic areas:
Lauren E. Abrey, MD
Memorial Sloan Kettering Cancer Center
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (7)
Showing 7 of 7 trials
Radiation Therapy With and Without Combination Chemotherapy in Patients With Resected Anaplastic Oligodendroglioma
Temozolomide in Treating Patients With Recurrent Oligodendroglial Tumors
Temozolomide in Treating Patients With Recurrent Oligodendroglial Tumors
Glufosfamide in Treating Patients With Recurrent Glioblastoma Multiforme
Imatinib Mesylate in Treating Patients With Gliomas
Erlotinib Compared With Temozolomide or Carmustine in Treating Patients With Recurrent Glioblastoma Multiforme
Bevacizumab in Recurrent Grade II and III Glioma
All 7 trials loaded